Evaxion A (EVAX) Return on Sales (2024 - 2026)
Evaxion A (EVAX) posted Return on Sales of 0.0% for Q1 2026, down 22.01% on a QoQ basis from 0.0% in Q4 2025, and up 5.0% year-over-year from 0.0% in Q1 2025.
Evaxion A (EVAX) Return on Sales (2024 - 2026) Analysis & Trends
Evaxion A's Return on Sales history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.
- Quarterly Return on Sales rose 5.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 5.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
- Return on Sales was 0.0% for Q1 2026 at Evaxion A, down from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.15% in Q1 2024 and bottomed at 0.43% in Q2 2024.
- A 3-year average of 0.07% and a median of 0.0% in 2026 frame the typical range for Return on Sales.
- Peak annual rise in Return on Sales reached 43 bps in 2025, while the deepest fall reached 19 bps in 2025.
- Evaxion A's Return on Sales stood at 0.34% in 2024, then soared by 100 bps to 0.0% in 2025, then fell by 22 bps to 0.0% in 2026.
- Business Quant data shows EVAX's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.34% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.43% |
| Mar 31, 2024 | 0.15% |